Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis

BACKGROUND Chronic rhinosinusitis (CRS) is a heterogeneous condition characterized by differing inflammatory endotypes. The identification of suitable biomarkers could enable personalized approaches to treatment selection. OBJECTIVE This study aimed to identify and summarize clinical studies of biomarkers in adults with CRS in order to inform future research into CRS endotypes. METHODS We conducted systematic searches of MEDLINE and Web of Science from inception to January 30, 2022 and included all clinical studies of adult CRS patients and healthy controls measuring biomarkers using enzyme-linked immunosorbent assays or Luminex immunoassays. Outcomes included the name and tissue type of identified biomarkers and expression patterns within CRS phenotypes. Study quality was assessed using the National Institutes of Health quality assessment tool for observational cohort and cross-sectional studies. A narrative synthesis was performed. RESULTS We identified 78 relevant studies involving up to 9394 patients, predominantly with CRS with nasal polyposis. Studies identified 80 biomarkers from nasal tissue, 25 from nasal secretions, 14 from nasal lavage fluid, 24 from serum, and one from urine. The majority of biomarkers found to distinguish CRS phenotypes were identified in nasal tissue, especially in nasal polyps. Serum biomarkers were more commonly found to differentiate CRS from controls. The most frequently measured biomarker was IL-5, followed by IL-13 and IL-4. Serum IgE, IL-17, pentraxin-3 and nasal phospho-janus kinase 2, IL-5, IL-6, IL-17A, granulocyte-colony stimulating factor, and interferon gamma were identified as correlated with disease severity. CONCLUSION We have identified numerous potential biomarkers to differentiate a range of CRS phenotypes. Future studies should focus on the prognostic role of nasal tissue biomarkers or expand on the more limited studies of nasal secretions and nasal lavage fluid.We registered this study in PROSPERO (CRD42022302787).

[1]  M. Kanakis,et al.  Periostin as a biomarker in chronic rhinosinusitis: A contemporary systematic review , 2022, International forum of allergy & rhinology.

[2]  G. Wang,et al.  Circulating BAFF as novel biomarker in distinguishing chronic rhinosinusitis with nasal polyps endotypes and predicting postoperative recurrence , 2022, International Immunopharmacology.

[3]  A. Bhalla,et al.  Vitamin D and Interleukins in Chronic Rhinosinusitis with Polyposis , 2022, Indian Journal of Otolaryngology and Head & Neck Surgery.

[4]  Jianbo Shi,et al.  Association Between Serum Amyloid A Expression and Disease Control after Endoscopic Sinus Surgery in Patients With Chronic Rhinosinusitis With Nasal Polyps. , 2021, Ear, nose, & throat journal.

[5]  Hua Zhang,et al.  The role of serum macrophage migration inhibitory factor in preoperative prediction of chronic rhinosinusitis with nasal polyps endotypes. , 2021, International immunopharmacology.

[6]  Yu-Tsai Lin,et al.  JAK2 Phosphorylation Signals and Their Associated Cytokines Involved in Chronic Rhinosinusitis with Nasal Polyps and Correlated with Disease Severity , 2021, Biomolecules.

[7]  W. Kong,et al.  Role of P2X7R in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps , 2021, Molecular medicine reports.

[8]  S. Vaitkus,et al.  Chronic Rhinosinusitis with Nasal Polyps: Age and Disease Severity Differences in the Levels of Inflammatory Markers , 2021, Medicina.

[9]  Timothy L. Smith,et al.  Olfactory cleft mucus inflammatory proteins in CRS: a case‐control study , 2021, International forum of allergy & rhinology.

[10]  A. Hamdan,et al.  Evaluation of Serum Total Immunoglobulin E, Interleukin-17 and Pentraxin-3 as Biomarkers for Chronic Rhinosinusitis With Nasal Polyposis , 2020, American journal of rhinology & allergy.

[11]  A. Peters,et al.  Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps. , 2020, The Journal of allergy and clinical immunology.

[12]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[13]  Ara Jo,et al.  Enhanced Type 2 Immune Reactions by Increased IL-22/IL-22Ra1 Signaling in Chronic Rhinosinusitis With Nasal Polyps , 2020, Allergy, asthma & immunology research.

[14]  A. Crăciun,et al.  Biochemical markers of inflammatory syndrome in chronic rhinosinusitis , 2020, Romanian Biotechnological Letters.

[15]  Seung-Heon Shin,et al.  Nasal Epithelial Cells Activated with Alternaria and House Dust Mite Induce Not Only Th2 but Also Th1 Immune Responses , 2020, International journal of molecular sciences.

[16]  Chengshuo Wang,et al.  Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma , 2020, Clinical and Translational Allergy.

[17]  Seung‐Kyu Chung,et al.  Age‐associated changes in chronic rhinosinusitis endotypes , 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  Chuling Li,et al.  Interleukin-33 Promotes Th2/Th17 Response in Eosinophilic and Non-Eosinophilic Nasal Polyps , 2019, ORL.

[19]  Su-Jin Shin,et al.  Diverse phenotypes and endotypes of fungus balls caused by mixed bacterial colonization in chronic rhinosinusitis , 2019, International forum of allergy & rhinology.

[20]  Joseph K. Han,et al.  Establishing Urinary Leukotriene E4 as a Diagnostic Biomarker for Chronic Rhinosinusitis with Comorbid Asthma and Atopy , 2019, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[21]  H. Lou,et al.  Epithelium-derived cystatin SN enhances eosinophil activation and infiltration through IL-5 in patients with chronic rhinosinusitis with nasal polyps. , 2019, The Journal of allergy and clinical immunology.

[22]  H. Kojima,et al.  JESREC score and mucosal eosinophilia can predict endotypes of chronic rhinosinusitis with nasal polyps. , 2019, Auris, nasus, larynx.

[23]  Seung‐Kyu Chung,et al.  Immunological Characteristics in Refractory Chronic Rhinosinusitis with Nasal Polyps Undergoing Revision Surgeries , 2019, Allergy, asthma & immunology research.

[24]  C. Hopkins,et al.  Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care , 2019, BMJ Open.

[25]  Dong‐Kyu Kim,et al.  Chronic Rhinosinusitis without Nasal Polyps in Asian Patients Shows Mixed Inflammatory Patterns and Neutrophil-Related Disease Severity , 2019, Mediators of inflammation.

[26]  Naweed I Chowdhury,et al.  Patterns of olfactory dysfunction in chronic rhinosinusitis identified by hierarchical cluster analysis and machine learning algorithms , 2018, International forum of allergy & rhinology.

[27]  Yun Ma,et al.  Interleukin‐4‒induced posttranscriptional gene regulation of CCL26 by the RNA‐binding protein HuR in primary human nasal polyp‒derived epithelial cells , 2018, International forum of allergy & rhinology.

[28]  Huabin Li,et al.  Excessive periostin expression and Th2 response in patients with nasal polyps: association with asthma. , 2018, Journal of thoracic disease.

[29]  Dae Woo Kim,et al.  Comparison Between Signature Cytokines of Nasal Tissues in Subtypes of Chronic Rhinosinusitis , 2018, Allergy, asthma & immunology research.

[30]  Yoo La Lee,et al.  Enhanced Interferon-β Response Contributes to Eosinophilic Chronic Rhinosinusitis , 2018, Front. Immunol..

[31]  C. Bachert,et al.  Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL‐5‐positive chronic rhinosinusitis with nasal polyps , 2018, Allergy.

[32]  M. Kohanski,et al.  Biomarkers in Chronic Rhinosinusitis with Nasal Polyps. , 2018, Immunology and allergy clinics of North America.

[33]  S. Zheng,et al.  Tc17/IL-17A Up-Regulated the Expression of MMP-9 via NF-κB Pathway in Nasal Epithelial Cells of Patients With Chronic Rhinosinusitis , 2018, Front. Immunol..

[34]  Da-Wei Li,et al.  Pro‐inflammatory role of transient receptor potential canonical channel 6 in the pathogenesis of chronic rhinosinusitis with nasal polyps , 2018, International forum of allergy & rhinology.

[35]  Huabin Li,et al.  Differential Hrd1 Expression and B-Cell Accumulation in Eosinophilic and Non-eosinophilic Chronic Rhinosinusitis With Nasal Polyps , 2018, Allergy, asthma & immunology research.

[36]  Kristine A. Smith,et al.  Calgranulin C (S100A12) Is Differentially Expressed in Subtypes of Chronic Rhinosinusitis , 2018, American journal of rhinology & allergy.

[37]  Dong‐Kyu Kim,et al.  Two-Track Medical Treatment Strategy According to the Clinical Scoring System for Chronic Rhinosinusitis , 2018, Allergy, asthma & immunology research.

[38]  Shukla Das,et al.  Serum Cytokine Profile in Patients with Chronic Rhinosinusitis with Nasal Polyposis Infected by Aspergillus flavus , 2017, Annals of laboratory medicine.

[39]  Geng Xu,et al.  Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: A pilot study. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[40]  Dae Woo Kim,et al.  Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine , 2017, Allergy, asthma & immunology research.

[41]  Sohee Oh,et al.  The role of interleukin-33 in chronic rhinosinusitis , 2016, Thorax.

[42]  C. Bachert,et al.  Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania. , 2016, The Journal of allergy and clinical immunology.

[43]  Zheng Liu,et al.  Distinct mucosal immunopathologic profiles in atopic and nonatopic chronic rhinosinusitis without nasal polyps in Central China , 2016, International forum of allergy & rhinology.

[44]  C. Bachert,et al.  Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. , 2016, The Journal of allergy and clinical immunology.

[45]  M. Gröger,et al.  Cytokine patterns in nasal secretion of non-atopic patients distinguish between chronic rhinosinusitis with or without nasal polys , 2016, Allergy, Asthma & Clinical Immunology.

[46]  J. Mo,et al.  Age-Related Decline of Neutrophilic Inflammation Is Associated with Better Postoperative Prognosis in Non-eosinophilic Nasal Polyps , 2016, PloS one.

[47]  C. Philpott,et al.  Chronic rhinosinusitis: patient experiences of primary and secondary care – a qualitative study , 2016, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[48]  Z. Soler,et al.  Reduced sinonasal levels of 1α‐hydroxylase are associated with worse quality of life in chronic rhinosinusitis with nasal polyps , 2016, International forum of allergy & rhinology.

[49]  E. Magen,et al.  Anticytokine autoantibodies in chronic rhinosinusitis. , 2015, Allergy and asthma proceedings.

[50]  Hyun-Woo Shin,et al.  IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis. , 2015, The Journal of allergy and clinical immunology.

[51]  Hanson Lu,et al.  Serum levels of specific IgE to Staphylococcus aureus enterotoxins in patients with chronic rhinosinusitis , 2015, Experimental and therapeutic medicine.

[52]  Shi Yu,et al.  Increased IL‐21 expression in chronic rhinosinusitis with nasalpolyps , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[53]  Chien‐Ho Chen,et al.  Serum Level of Interleukin-21 is Elevated in Chronic Rhinosinusitis , 2015, American journal of rhinology & allergy.

[54]  C. Bachert,et al.  Mixed T Helper Cell Signatures In Chronic Rhinosinusitis with and without Polyps , 2014, PloS one.

[55]  Luo Zhang,et al.  The Expression of Epithelial Intercellular Junctional Proteins in the Sinonasal Tissue of Subjects with Chronic Rhinosinusitis: A Histopathologic Study , 2014, ORL.

[56]  C. Bachert,et al.  Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. , 2013, The Journal of allergy and clinical immunology.

[57]  A. Peters,et al.  Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression. , 2013, The Journal of allergy and clinical immunology.

[58]  E. Banoglu,et al.  Serum interleukin‐16 levels in patients with nasal polyposis , 2012, The Laryngoscope.

[59]  J Bousquet,et al.  Chronic rhinosinusitis in Europe – an underestimated disease. A GA2LEN study , 2011, Allergy.

[60]  H. Stammberger,et al.  Released intranasal eosinophilic major basic protein as a diagnostic marker for polypoid chronic rhinosinusitis , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[61]  C. Bachert,et al.  Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis. , 2010, The Journal of allergy and clinical immunology.

[62]  A. Peters,et al.  Rhinitis , sinusitis , and upper airway disease Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps , 2022 .

[63]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[64]  C. Bachert,et al.  Differential expression of the interleukin 5 receptor α isoforms in blood and tissue eosinophils of nasal polyp patients , 2009, Allergy.

[65]  Xiang Lu,et al.  Clara cell 10‐kDa protein expression in chronic rhinosinusitis and its cytokine‐driven regulation in sinonasal mucosa , 2009, Allergy.

[66]  C. Bachert,et al.  Local immunoglobulin production in nasal polyposis is modulated by superantigens , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[67]  V. Lund,et al.  The Lund-Mackay staging system for chronic rhinosinusitis: How is it used and what does it predict? , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[68]  C. Bachert,et al.  Expression of eicosanoid receptors subtypes and eosinophilic inflammation: implication on chronic rhinosinusitis , 2006, Respiratory research.

[69]  J. Pearson,et al.  Major Secretory Mucin Expression in Chronic Sinusitis , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[70]  A. Falus,et al.  The Pathogenesis of Nasal Polyposis by Immunoglobulin E and Interleukin‐5 Is Completed by Transforming Growth Factor‐β1 , 2003, The Laryngoscope.

[71]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[72]  R. Metson,et al.  Periostin as a Biomarker for Nasal Polyps in Chronic Rhinosinusitis , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[73]  Christopher F. Thompson,et al.  Proton pump inhibitors decrease eotaxin‐3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K‐ATPase , 2017, The Journal of allergy and clinical immunology.

[74]  M. Yılmaz,et al.  The role of IL-25 and IL-33 in chronic rhinosinusitis with or without nasal polyps , 2016, European Archives of Oto-Rhino-Laryngology.